Joshua Eizen

Joshua Eizen

Directeur des opérations chez AN2 THERAPEUTICS, INC.

Fortune : 281 446 $ au 31/05/2026

48 ans
Health Technology
Consumer Services
Commercial Services

Profil

Joshua Eizen is currently Secretary, Chief Operating & Legal Officer at AN2 Therapeutics, Inc. since 2024.
Formerly, Mr. Eizen was VP & Associate General Counsel at Jazz Pharmaceuticals, Inc. from 2021 to 2022; VP & General Counsel at GW Pharmaceuticals Ltd. from 2018 to 2021; Associate Chief Counsel-Enforcement at the US Food & Drug Administration from 2008 to 2014; Chief Compliance Officer & General Counsel at Pulmonary Hypertension Association, Inc. from 2015 to 2018; Associate at McKee Nelson LLP; and Chief Compliance Officer & Senior Counsel at Actelion Pharmaceuticals US, Inc. from 2015 to 2018.
Education includes undergraduate and graduate degrees from Case Western Reserve University and a graduate degree from Georgetown University Law Center.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 64 999 ( 0,18% ) 281 446 $ 31/05/2026

Postes actifs de Joshua Eizen

SociétésPosteDébut
AN2 THERAPEUTICS, INC. Directeur des opérations 04/11/2024

Anciens postes connus de Joshua Eizen

SociétésPosteFin
Corporate Officer/Principal 01/09/2022
GW PHARMACEUTICALS PLC Corporate Officer/Principal 01/05/2021
Compliance Officer 01/06/2018
Compliance Officer 01/06/2018
Corporate Officer/Principal 01/10/2014
Voir l'expérience en détail de Joshua Eizen

Formation de Joshua Eizen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

15

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Commercial Services

Consumer Services

Government

Health Technology

Health Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Joshua Eizen